Dual Arc Volumetric-modulated Arc Radiotherapy (VMAT) of Nasopharyngeal Carcinomas: A Simultaneous Integrated Boost Treatment Plan Comparison with Intensity-modulated Radiotherapies and Single Arc VMAT

Clinical Oncology

Volumn 24, Issue 3, 2012, Pages 196-207

  Lee, T F ^a   Ting, H M ^a,b   Chao, P J ^a,b   Fang, F M ^b  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Delivery time; Dual arc; IMRT; NPC; VMAT

Indexed keywords

ACCURACY; ADULT; ALGORITHM; ARTICLE; BRAIN STEM; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLLIMATOR; DUAL ARC VOLUMETRIC MODULATED ARC RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; MANDIBLE; MOUTH CAVITY; NASOPHARYNX CARCINOMA; PAROTID GLAND; PRIORITY JOURNAL; PROBABILITY; PROCESS OPTIMIZATION; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; SINGLE ARC VOLUMETRIC MODULATED ARC RADIOTHERAPY; SPINAL CORD; TISSUES; TREATMENT PLANNING; VISUAL SYSTEM;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; ORGANS AT RISK; PHOTONS; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84857920936     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.06.006     Document Type: Article

References (49)

1. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008, 35:310-317.
2. Bertelsen A., Hansen C.R., Johansen J., et al. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother Oncol 2010, 95(2):142-148.
3. Clivio A., Fogliata A., Franzetti-Pellanda A., et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009, 92(1):118-124.
4. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008, 89(2):180-191.
5. Fogliata A., Clivio A., Nicolini G., et al. Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol 2008, 89(3):254-262.
6. Vanetti E., Clivio A., Nicolini G., et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009, 92(1):111-117.
7. Verbakel W.F.A.R., Cuijpers J.P., Hoffmans D., et al. Volumetric intensity-modulated arc therapy vs. conventional imrt in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 2009, 74(1):252-259.
8. Bzdusek K., Friberger H., Eriksson K., et al. Development and evaluation of an efficient approach to volumetric arc therapy planning. Med Phys 2009, 36:2328-2339.
9. Rao M., Yang W., Chen F., et al. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. Med Phys 2010, 37(3):1350-1359.
10. Lee N, Harris J, Garden AS et al. RTOG 0225, A Phase II study of intensity modulated radiation therapy (IMRT) +/- chemotherapy for nasopharyngeal cancer. http://www.rtog.org/members/protocols/0225/0225.
11. Lee N, Pfister DG, Garden A, et al. RTOG 0615, A phase II study of concurrent chemoradiotherapy using three dimentional conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. http://www.rtog.org/members/protocols/0615/0615.
12. Lee N., Harris J., Garden A.S., et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27(22):3684.
13. Lin K., Liu J., Lee N. Advances in the technology of radiation therapy for nasopharyngeal carcinoma. Clinical radiation oncology 2007, Churchill Livingstone, PA, 197-211. L. Gunderson, J. Tepper (Eds.).
14. Hardemark B., Liander A., Rehbinder H., et al. P3IMRT. Direct machine parameter optimisation. Pinnacle White Paper no. 4535-983-02483. Philips 2004.
15. Hardemark B., Liander A., Rehbinder H., et al. P3IMRT. Biological optimisation and EUD. Pinnacle White Paper no. 4535-983-02482. Philips 2004.
16. Bedford J.L., Warrington A.P. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys 2009, 73(2):537-545.
17. Bortfeld T., Webb S. Single-arc IMRT?. Phys Med Biol 2009, 54:N9.
18. Hardcastle N, Tomé WA, Foo K, et al. Comparison of prostate IMRT and VMAT biologically optimised treatment plans. Med Dosim, in press, . doi:10.1016/j.meddos.2010.06.001.
19. Feygelman V., Zhang G., Stevens C. Initial dosimetric evaluation of SmartArc - a novel VMAT treatment planning module implemented in a multi-vendor delivery chain. J Appl Clin Med Phys 2010, 11(1):99-116.
20. Zacarias A.S., Brown M.F., Mills M.D. Volumetric modulated arc therapy (VMAT) treatment planning for superficial tumors. Med Dosim 2010, 35:226-229.
21. Lee T.-F., Fang F.-M., Chao P.-J., et al. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol 2008, 89(1):89-96.
22. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 2000, 93(Suppl. 3):219-222.
23. Sheng K., Molloy J.A., Read P.W. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys 2006, 65(3):917-923.
24. Xia P., Fu K.K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000, 48(2):329-337.
25. Lee T.-F., Chao P.-J., Fang F.-M., et al. Helical tomotherapy for single and multiple liver tumours. Radiother Oncol 2010, 5(1):58.
26. Sanchez-Nieto B., Nahum A. The delta-TCP concept: a clinically useful measure of tumor control probability. Int J Radiat Oncol Biol Phys 1999, 44(2):369-380.
27. Gay H., Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Medica 2007, 23(3-4):115-125.
28. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21(1):109.
29. Lee T., Rosen I., Gibbons J., et al. Helical tomotherapy for parotid gland tumors. Int J Radiat Oncol Biol Phys 2008, 70(3):883-891.
30. Wu Q., Mohan R., Niemierko A., et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002, 52(1):224-235.
31. Taheri-Kadkhoda Z., Pettersson N., Bjork-Eriksson T., et al. Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study. Br J Radiol 2008, 81(965):397.
32. Li J., Shan Z., Ou G., et al. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys 2005, 62(5):1510-1516.
33. MacDonald S., Ahmad S., Kachris S., et al. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys 2007, 8(2):47.
34. Luxton G., Keall P., King C. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD). Phys Med Biol 2008, 53:23.
35. Petera J., Matula P., Paluska P., et al. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study. Neoplasma 2009, 56(2):163.
36. Van Esch A., Clermont C., Devillers M., et al. On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom. Med Phys 2007, 34:3825.
37. Vanetti E., Nicolini G., Clivio A., et al. The impact of treatment couch modelling on RapidArc. Phys Med Biol 2009, 54:N157-N166.
38. Low D., Harms W., Mutic S., et al. A technique for the quantitative evaluation of dose distributions. Med Phys 1998, 25:656-661.
39. Pallant J. SPSS survival manual. Milton Keynes 2007, Open University Press.
40. Hair J.F., Black W.C., Babin B.J., et al. Multivariate data analysis 2009, Pearson Education, Upper Saddle River, NJ. 7th edn.
41. Stevens J. Applied multivariate statistics for the social sciences 2009, Lawrence Erlbaum Associates, Mahwah, NJ. 5th edn.
42. Tapola N., Karvonen H., Niskanen L., et al. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Carbiovasc Dis 2005, 15(4):255-261.
43. Doornaert P., Verbakel W.F.A.R., Bieker M., et al. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy. Int J Radiat Oncol Biol Phys 2011, 79:429-435.
44. Nicolini G., Clivio A., Fogliata A., et al. Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. Radiat Oncol 2009, 4:27.
45. Popescu C.C., Olivotto I.A., Beckham W.A., et al. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulatedradiotherapy for locoregional radiotherapy of left-sidedbreast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 2010, 76(1):287-295.
46. Eppinga W., Lagerwaard F.J., Verbakel W.F.A.R., et al. Conventional IMRT versus volumetric modulated arc therapy (rapidarc) for pancreatic cancer. Int J Radiat Oncol Biol Phys 2009, 75(3, Suppl. 1):S712.
47. Guckenberger M., Richter A., Krieger T., et al. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?. Radiother Oncol 2009, 93(2):259-265.
48. Mans A., Remeijer P., Olaciregui-Ruiz I., et al. 3D dosimetric verification of volumetric-modulated arc therapy by portal dosimetry. Radiother Oncol 2010, 94(2):181-187.
49. Fang F.-M., Chien C.-Y., Tsai W.-L., et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 2008, 72(2):356-364.